Virtual patent marking notice

This website is provided to satisfy the virtual patent marking provisions of various jurisdictions including the virtual patent marking provisions of United States law, and to provide notice under 35 U.S.C. Section 287(a).  The following list of products may not include all of Axogen’s products. The patents identified for each product may also not be all inclusive. For example, some products listed below may be protected by patents of the United States or another country and which are not identified below. Other products not listed here may be protected by one or more patents of the United States or elsewhere.

Avance® Nerve Graft

Product codes for United States:
111215; 211215; 311215; 411215; 111230; 211230; 311230; 411230; 111250; 211250; 311250; 411250; 111270; 211270; 311270; 411270

Product of and/or manufactured according to a method of United States Patent Nos. 6,972,168; 7,732,200; 8,758,794; 9,402,868; 9,597,429; 10,441,681
Product codes for Germany:
113215; 213215; 313215; 413215; 113230; 213230; 313230; 413230; 113250; 213250; 313250; 413250; 113270; 213270; 313270; 413270Product codes for all other countries:
112215; 212215; 312215; 412215; 112230; 212230; 312230; 412230; 112250; 212250; 312250; 412250; 112270; 212270; 312270; 412270
Manufactured according to the method of European Patent No. 1425390 (CH, DE, ES, GB, SE)
Axoguard Nerve Cap®

Product codes for United States, New Zealand:
AGT215, AGT315, AGT415, AGT520, AGT620, AGT720

Product of United States Patent Nos. 9,629,997; 10,945,805; 10,952,806; and other pending patent applications in the United States and other countries